Lynk Solutec, a medical device surface coating technology company led by CEO Jungmok Seo, has announced the acquisition of two innovative coating technology patents that can significantly enhance safety in medical settings. The newly registered patents are for “Medical Implant Coating Composition for Foreign Material Prevention” and “Suture Coating Composition for Foreign Material Prevention.”

The core of these newly developed coating technologies lies in their special composition that fundamentally prevents the adhesion of all foreign materials, including blood, moisture, mucus, and bacteria. CTO Yeonteak Lee explained, “Medical implants and sutures come into contact with various foreign substances within the body, such as blood, mucus, bacteria, cells, and calcification. The adhesion of these substances can cause serious side effects, including infections, inflammation, and thrombosis formation. These patent technologies provide an innovative solution that fundamentally addresses these issues.”

The implant coating technology can be applied to a wide range of medical devices, including various types of stents for the esophagus, blood vessels, bile duct, gallbladder, pancreas, uterus, urethra, and ureter, as well as drainage catheters, injection catheters, parenteral catheters, and urological catheters. The suture coating technology is applicable to all types of sutures, including dental/ophthalmic and microsurgical sutures. Notably, unlike existing coating technologies, these new innovations allow for additional lubricant coating on top of the coated medical devices, further enhancing their performance.

CEO Jungmok Seo emphasized, “These patent technologies can dramatically reduce medical device-related complications. In particular, they can significantly improve the safety and accuracy of surgical procedures by minimizing the risks of infection, inflammation, and thrombosis formation.” He also added, “We are currently preparing for clinical trials to commercialize these patent technologies and plan to complete product development in the near future.”

Lynk Solutec, a spin-off company from the BioLogical Interfaces and Sensor Systems Laboratory at Yonsei University, continues to drive innovation in medical settings through its medical device coating technologies.

Jung-mok Seo, CEO of Lynk Solutec, a company developing innovative medical devices based on medical device coating technology, was invited as a speaker at the 2024 Yonsei University Laboratory Startup Conference.

During the event, CEO Seo presented successful cases of technology startups as a professor in the Department of Electrical and Electronic Engineering. Leading the Yonsei University BioLogical Interface and Sensor Systems Laboratory, he developed a coating technology that can fundamentally inhibit infection, inflammation, and thrombosis for the first time in the world. He shared vibrant examples of how he is expanding his business by showcasing innovative medical devices such as “an endoscopic cap that provides a clear surgical view” and “a ureteral stent that inhibits calcification”

In the following “Laboratory Startup Talk Concert,” he participated in a panel discussion with the Yonsei University Startup Support Team. CEO Seo shared insights on the development direction and challenges of the laboratory startup ecosystem, drawing significant interest from the audience.

Lynk Solutec, a company developing innovative medical devices based on medical device coating technology, is accelerating its entry into the global medical device market with its ISO 13485 certification.

Lynk Solutec has obtained ISO 13485 certification for the design, development, manufacturing, and sales of non-absorbable sutures and endoscopic connectors. This certification signifies that the company has facilities that produce innovative products such as the award-winning ‘Endoscopic Cap’ at CES 2024 and the scarce ‘Non-Absorbable Sutures for Ptosis,’ which have been designated as rare medical devices, all in compliance with international standards.

ISO 13485 is an international standard for medical device quality management systems, ensuring that a company meets global requirements for management and quality control from development to production of medical devices. It is known that this certification can only be obtained by meeting the stringent requirements of countries with high-quality standards such as Europe and Canada, and companies that receive this certification are considered qualified to export medical devices to major countries worldwide.

Lynk Solutec is a spin-off company from BioLogical interfaces and Sensor Systems Laboratory at Yonsei University and has developed the ‘Lynk Coating’ medical coating technology, which addresses surgical complications such as infections, inflammation, and thrombosis. Utilizing this technology, the company has introduced innovative medical devices like endoscopic caps that provide clear vision during endoscopic surgery and ureteral stents that prevent encrustation.

A workshop was held for 2 days from June 20 to revitalize convergence research between Yonsei Health System and Yonsei University of Engineering and to develop researchers’ technological commercialization capabilities.

The workshop was attended by 35 professors from Yonsei Health System and Yonsei University of Engineering and was organized to share cases linking research results to commercialization and discuss cooperation.

Jungmok Seo, CEO of Lynk Solutec (Professor of the Department of Electrical and Electronic Engineering at Yonsei University), introduced medical device coating technology under the theme of “Innovative Medical Devices Through Prevention of Bio-adhesion.”

Lynk Coating, developed by CEO Seo, is a patented coating technology that prevents the attachment of bio-materials such as blood, mucus, and bacteria. Unlike the existing technology, it can be applied to various materials such as glass, polymer, and plastic, and can be coated stably in complex structures, drawing attention from industry and academia.

Based on this coating technology, Lynk Solutec has released a disposable cap C.E.V. (Clear Endo Vision) to help secure vision during endoscopic surgery and is developing ureter stents that prevent crust formation and non-absorbable sutures designated as rare medical devices.